Cargando…

The Clinical Characteristics of Other HLA-B Types in Chinese Ankylosing Spondylitis Patients

HLA-B27 has an established relationship with the development of ankylosing spondylitis (AS). After reviewing the HLA-B genotype from 407 Chinese subjects (318 patients and 89 sex-matched controls), we found that 252 patients and 32 controls were HLA-B27(+) and that HLA-B(*)27:04 was the dominant HLA...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xinyu, Wu, Jialing, Li, Xiaomin, Wei, Qiujing, Lv, Qing, Zhang, Pingping, Zheng, Xuqi, Chen, Zena, Cao, Shuangyan, Tu, Liudan, Gu, Jieruo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820707/
https://www.ncbi.nlm.nih.gov/pubmed/33490092
http://dx.doi.org/10.3389/fmed.2020.568790
_version_ 1783639270677807104
author Wu, Xinyu
Wu, Jialing
Li, Xiaomin
Wei, Qiujing
Lv, Qing
Zhang, Pingping
Zheng, Xuqi
Chen, Zena
Cao, Shuangyan
Tu, Liudan
Gu, Jieruo
author_facet Wu, Xinyu
Wu, Jialing
Li, Xiaomin
Wei, Qiujing
Lv, Qing
Zhang, Pingping
Zheng, Xuqi
Chen, Zena
Cao, Shuangyan
Tu, Liudan
Gu, Jieruo
author_sort Wu, Xinyu
collection PubMed
description HLA-B27 has an established relationship with the development of ankylosing spondylitis (AS). After reviewing the HLA-B genotype from 407 Chinese subjects (318 patients and 89 sex-matched controls), we found that 252 patients and 32 controls were HLA-B27(+) and that HLA-B(*)27:04 was the dominant HLA-B27 subtype (N = 224). In all participants, HLA(*)27:04 homozygous were only detected in two patients. In the HLA-B27(+) group, HLA-B40 was observed in 51 cases and one control (p < 0.05, OR = 7.87, 95% CI 1.05–59.0); of these, the most genotype was HLA-B(*)27:04/B(*)40:01(N = 38). Two hundred thirty-nine patients' clinical information was recorded. Cases with HLA-B27/B46 had more peripheral joint involvement (OR = 3.95, 95% CI 1.77–8.79) in HLA-B27(+) AS. HLA-B(*)15:02 may be a significant risk element to peripheral joint involvement (p < 0.05) in HLA-B27(−) patients. Therefore, we believe HLA-B(*)40:01, HLA-B(*)46:01, and HLA-B(*)15:02 can be the test indicators for AS diagnostic value.
format Online
Article
Text
id pubmed-7820707
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-78207072021-01-23 The Clinical Characteristics of Other HLA-B Types in Chinese Ankylosing Spondylitis Patients Wu, Xinyu Wu, Jialing Li, Xiaomin Wei, Qiujing Lv, Qing Zhang, Pingping Zheng, Xuqi Chen, Zena Cao, Shuangyan Tu, Liudan Gu, Jieruo Front Med (Lausanne) Medicine HLA-B27 has an established relationship with the development of ankylosing spondylitis (AS). After reviewing the HLA-B genotype from 407 Chinese subjects (318 patients and 89 sex-matched controls), we found that 252 patients and 32 controls were HLA-B27(+) and that HLA-B(*)27:04 was the dominant HLA-B27 subtype (N = 224). In all participants, HLA(*)27:04 homozygous were only detected in two patients. In the HLA-B27(+) group, HLA-B40 was observed in 51 cases and one control (p < 0.05, OR = 7.87, 95% CI 1.05–59.0); of these, the most genotype was HLA-B(*)27:04/B(*)40:01(N = 38). Two hundred thirty-nine patients' clinical information was recorded. Cases with HLA-B27/B46 had more peripheral joint involvement (OR = 3.95, 95% CI 1.77–8.79) in HLA-B27(+) AS. HLA-B(*)15:02 may be a significant risk element to peripheral joint involvement (p < 0.05) in HLA-B27(−) patients. Therefore, we believe HLA-B(*)40:01, HLA-B(*)46:01, and HLA-B(*)15:02 can be the test indicators for AS diagnostic value. Frontiers Media S.A. 2021-01-08 /pmc/articles/PMC7820707/ /pubmed/33490092 http://dx.doi.org/10.3389/fmed.2020.568790 Text en Copyright © 2021 Wu, Wu, Li, Wei, Lv, Zhang, Zheng, Chen, Cao, Tu and Gu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Wu, Xinyu
Wu, Jialing
Li, Xiaomin
Wei, Qiujing
Lv, Qing
Zhang, Pingping
Zheng, Xuqi
Chen, Zena
Cao, Shuangyan
Tu, Liudan
Gu, Jieruo
The Clinical Characteristics of Other HLA-B Types in Chinese Ankylosing Spondylitis Patients
title The Clinical Characteristics of Other HLA-B Types in Chinese Ankylosing Spondylitis Patients
title_full The Clinical Characteristics of Other HLA-B Types in Chinese Ankylosing Spondylitis Patients
title_fullStr The Clinical Characteristics of Other HLA-B Types in Chinese Ankylosing Spondylitis Patients
title_full_unstemmed The Clinical Characteristics of Other HLA-B Types in Chinese Ankylosing Spondylitis Patients
title_short The Clinical Characteristics of Other HLA-B Types in Chinese Ankylosing Spondylitis Patients
title_sort clinical characteristics of other hla-b types in chinese ankylosing spondylitis patients
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820707/
https://www.ncbi.nlm.nih.gov/pubmed/33490092
http://dx.doi.org/10.3389/fmed.2020.568790
work_keys_str_mv AT wuxinyu theclinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients
AT wujialing theclinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients
AT lixiaomin theclinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients
AT weiqiujing theclinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients
AT lvqing theclinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients
AT zhangpingping theclinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients
AT zhengxuqi theclinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients
AT chenzena theclinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients
AT caoshuangyan theclinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients
AT tuliudan theclinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients
AT gujieruo theclinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients
AT wuxinyu clinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients
AT wujialing clinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients
AT lixiaomin clinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients
AT weiqiujing clinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients
AT lvqing clinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients
AT zhangpingping clinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients
AT zhengxuqi clinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients
AT chenzena clinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients
AT caoshuangyan clinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients
AT tuliudan clinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients
AT gujieruo clinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients